Companies: 10,795·Total market cap: $144.5T
Bicycle Therapeutics plc

Bicycle Therapeutics plc

BCYCNASDAQHealthcare● Active
$4.21
+$0.01(+0.12%)
Market Cap$291804020
P/E Ratio—
52W High$9.36
52W Low$4.075
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Bicycle Therapeutics plc (BCYC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001761612 · BCYC · NASDAQ · as of Jun 8, 2026

Filing snapshot

634
Total Filings
8-K
Latest Form
2026-05-21
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001761612 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-17
Fiscal Year End
Mar 17, 2026
Accession No.
0001104659-26-028971
Primary Document
bcyc-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001761612 · Accession 0001104659-26-028971

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2026-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-05-21
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-04
View
10-QQuarterly Report
10-Q
2026-04-30
View
8-KCurrent Report
FORM 8-K
2026-04-30
View
ARSARS
ARS
2026-04-22
View
DEF 14AProxy Statement
DEF 14A
2026-04-22
View
8-KCurrent Report
FORM 8-K
2026-04-20
View
PRE 14APRE 14A
PRE 14A
2026-04-03
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-25
View
S-8Employee Stock Plan Registration
FORM S-8
2026-03-17
View
10-KAnnual Report
10-K
2026-03-17
View
8-KCurrent Report
FORM 8-K
2026-03-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-04
View
Showing 1–15 of 305 filingsForm 4 / 144 hidden· 634 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001761612  |  Exchange: NASDAQ · Healthcare

Bicycle Therapeutics plc (NASDAQ: BCYC) has submitted 634 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001761612, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Bicycle Therapeutics plc's most comprehensive regulatory disclosure. The most recent Bicycle Therapeutics plc 10-K was filed on 2026-03-17 for fiscal year ending 2026. Historical BCYC 10-K annual reports are available from 2018 through 2026.

Investors researching Bicycle Therapeutics plc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KALV SEC Filings →RAPT SEC Filings →LXRX SEC Filings →OMER SEC Filings →PRTA SEC Filings →FDMT SEC Filings →NMRA SEC Filings →CMPX SEC Filings →
→ BCYC Financials→ BCYC Earnings→ BCYC Insider Trades

Frequently Asked Questions

BCYC SEC Filings · 8 questions

Bicycle Therapeutics plc (BCYC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 634 filings and access original documents at no cost. Bicycle Therapeutics plc's CIK is 0001761612.

BCYC SEC filingsBicycle Therapeutics plc SEC documentsfind BCYC 10-K